Critics Say Assemblymember Liz Ortega Was Misled Into Supporting SIBTF Reforms That Targeted Disabled Californians

Critics Say Assemblymember Liz Ortega Was Misled Into Supporting SIBTF Reforms That Targeted Disabled Californians

January 13, 2026 | Sacramento, CA — MedLegalNews.com — California Assemblymember Liz Ortega, a prominent labor leader and Chair of the Assembly Committee on Labor and Employment, has come under sustained criticism from disability advocates and workers’ compensation attorneys who argue that she was misled — or “hoodwinked,” in their words — into advancing policy proposals that […]

Critics Say Assemblymember Liz Ortega Was Misled Into Supporting SIBTF Reforms That Targeted Disabled Californians Read Post »

Questions Raised Over 2024 RAND SIBTF Liability Study

Questions Raised Over 2024 RAND SIBTF Liability Study

January 7, 2026 — An investigation by The Jacobi Journal reports that the RAND Corporation’s 2024 study of California’s Subsequent Injuries Benefits Trust Fund (SIBTF) may have overstated the fund’s projected unfunded liability by approximately $6.75 billion, or about 632%, compared with the Journal’s recalculated estimate. The RAND study’s headline figure of a $7.9 billion

Questions Raised Over 2024 RAND SIBTF Liability Study Read Post »

California’s SB 40 Caps Insulin Costs: Key Details for Insurers and Patients

California’s SB 40 Caps Insulin Costs: Key Details for Insurers and Patients

January 5, 2026 | Sacramento, CA — MedLegalNews.com — Starting January 1, 2026, California implements SB 40, landmark legislation designed to address the state’s ongoing insulin affordability crisis. The law caps out-of-pocket insulin costs for patients covered by large, state-regulated health insurers, limiting a 30-day supply to a $35 copay. Additionally, the suggested retail price

California’s SB 40 Caps Insulin Costs: Key Details for Insurers and Patients Read Post »

California Lawmakers Target Licensing Barriers for Alternative Birth Centers Under AB 55

California Lawmakers Target Licensing Barriers for Alternative Birth Centers Under AB 55

January 3, 2026 | Sacramento, CA — MedLegalNews.com — California is taking another step toward reshaping its maternal healthcare framework as lawmakers revisit long-standing regulatory hurdles affecting alternative birth centers. AB 55 (Bonta) focuses on expanding access to licensed, midwife-led birth centers while addressing persistent reimbursement challenges under Medi-Cal—an issue that has limited care options

California Lawmakers Target Licensing Barriers for Alternative Birth Centers Under AB 55 Read Post »

Johnson & Johnson Slapped With $1.5 Billion Talc Verdict in Baltimore Mesothelioma Case

Johnson & Johnson Slapped With $1.5 Billion Talc Verdict in Baltimore Mesothelioma Case

December 31, 2025 | Los Angeles, CA — MedLegalNews.com — A Baltimore jury has delivered one of the most consequential talc-related verdicts of the year, ordering Johnson & Johnson to pay more than $1.5 billion to a woman who developed mesothelioma after decades of alleged exposure to the company’s talc-based products. According to trial testimony,

Johnson & Johnson Slapped With $1.5 Billion Talc Verdict in Baltimore Mesothelioma Case Read Post »

Punitive Damages Denied in Nursing Home Death Lawsuit After Appeals Court Review

Punitive Damages Denied in Nursing Home Death Lawsuit After Appeals Court Review

December 29, 2025 | Tallahassee, FL — MedLegalNews.com — A Florida state appeals court has upheld a lower court ruling denying a request to pursue punitive damages in a wrongful death lawsuit involving a nursing home resident who suffered a rare spinal fracture prior to death. The appellate panel concluded that the evidence presented failed

Punitive Damages Denied in Nursing Home Death Lawsuit After Appeals Court Review Read Post »

Purdue Pharma’s $7.4 Billion Chapter 11 Plan Poised for Court Confirmation

Purdue Pharma’s $7.4 Billion Chapter 11 Plan Poised for Court Confirmation

December 24, 2025 | Washington, D.C. — MedLegalNews.com — Purdue Pharma’s long-running Chapter 11 bankruptcy case is nearing a decisive moment, as a federal court prepares to confirm a revised $7.4 billion reorganization plan designed to resolve thousands of opioid-related claims nationwide. The confirmation would mark one of the most significant mass tort resolutions in

Purdue Pharma’s $7.4 Billion Chapter 11 Plan Poised for Court Confirmation Read Post »

Heightened State Oversight Reshapes Health Care Investment Landscape

Heightened State Oversight Reshapes Health Care Investment Landscape

December 22, 2025 | Sacramento, CA — MedLegalNews.com — State governments are asserting unprecedented control over health care transactions, signaling a major shift in how investors, providers, and dealmakers must approach the sector in 2026. What was once a largely federal conversation about consolidation and private equity involvement has now moved decisively to the state

Heightened State Oversight Reshapes Health Care Investment Landscape Read Post »

Celebrity Esthetician Sued Over Alleged Burns From Cosmetic Procedure

Celebrity Esthetician Sued Over Alleged Burns From Cosmetic Procedure

December 19, 2025 | Los Angeles, CA – MedLegalNews.com – A Los Angeles woman has filed a lawsuit against a celebrity esthetician, claiming that a cosmetic procedure performed by the celebrity esthetician left her with severe burns and permanent facial scarring. The legal action underscores the increasing scrutiny of cosmetic treatments and the potential risks

Celebrity Esthetician Sued Over Alleged Burns From Cosmetic Procedure Read Post »

California Stem Cell Clinic Ends $10 Million Malpractice Lawsuit

California Stem Cell Clinic Ends $10 Million Malpractice Lawsuit

December 17, 2025 | Los Angeles, CA – MedLegalNews.com – A California-based stem cell clinic has formally dismissed its $10 million lawsuit against a law firm involved in a previous wrongful-death case. The litigation stemmed from allegations linked to a spinal stem cell injection that resulted in a patient’s death. The case was dismissed with

California Stem Cell Clinic Ends $10 Million Malpractice Lawsuit Read Post »

Scroll to Top